Day: May 4, 2020

RICHLAND, Wash., May 04, 2020 (GLOBE NEWSWIRE) —  Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in brachytherapy powering expanding treatment options throughout the body, today announced that it will host a conference call to discuss its financial results for the third quarter fiscal 2020 ended March 31, 2020 on Tuesday, May 12, 2020, at 4:30 p.m. Eastern Time. The Company will issue a press release announcing its financial results for the third quarter fiscal 2020 after the close of the U.S. stock markets on May 12, 2020. To listen to the conference call, please dial 844-602-0380. For callers outside the U.S., please dial 862-298-0970.The conference call will be simultaneously webcast and can be accessed at https://www.webcaster4.com/Webcast/Page/2199/34448 by clicking on the link. The webcast will...

– Management to host conference call and webcast on Monday, May 11 at 8:30 a.m. ET-NORWOOD, MA, May 04, 2020 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that it will report its first quarter financial results on Monday, May 11. Corbus management will host a conference call and live audio webcast to discuss operational and financial results at 8:30 a.m. ET that same day.The call will be led by Yuval Cohen, Ph.D., Chief Executive Officer of Corbus. He will be joined by additional members of the Corbus management team. Interested participants and investors may access the conference call by dialing (877) 407-3978 (domestic) or (412) 902-0039...

CORAL GABLES, Fla., May 04, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today announced that it will release first quarter 2020 financial results after market close on Monday, May 11, 2020. Further, Catalyst management will host an investment-community conference call at 8:30 a.m. ET on Tuesday, May 12, 2020 to discuss the financial results and to provide a corporate update.Investors who wish to participate in the conference call may do so by dialing (877) 407-8912 for domestic and Canadian callers or (201) 689-8059 for international callers. Those interested in listening to the conference call live via...

NEW YORK, May 04, 2020 (GLOBE NEWSWIRE) — Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for Seelos’ U.S. patent number 10,437,637 (application number 16/263,707) titled “COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER” for trehalose (SLS-005).The allowed claims cover the composition of matter and method of use for trehalose (SLS-005) for treating a disease or disorder selected from any one of the following: Spinal and bulbar muscular atrophy (SBMA); Dentatombral-pallidoluysian atrophy (DRPLA); Pick’s disease; corticobasal degeneration (CBD); progressive...

— Antolimab treatment provided durable symptom improvement and blood and tissue eosinophil depletion —— Symptomatic benefit increased with duration of antolimab treatment —REDWOOD CITY, Calif., May 04, 2020 (GLOBE NEWSWIRE) — Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antolimab (AK002) for the treatment of eosinophil and mast cell-related diseases, today reported results from a long-term open-label extension (OLE) study of antolimab for the treatment of patients with eosinophilic gastritis (EG) and/or eosinophilic duodenitis (EoD). The results were accepted for oral presentation and presented virtually at the Digestive Disease Week (DDW) Annual Meeting. The Company previously announced the initiation of a Phase 3 study in EG and/or EoD and initiation of a Phase 2/3 study...

NEW YORK, May 04, 2020 (GLOBE NEWSWIRE) — Mohawk Group Holdings, Inc. (NASDAQ: MWK) (“Mohawk”), today announced that the company will release its financial results for the first quarter 2020, after the market close on Monday, May 11, 2020. Management will host a conference call that afternoon (May 11, 2020) at 5:00 p.m. ET to discuss the financial results.Investors and analysts interested in participating in the call are invited to dial (877) 295-1077 (domestic) or (470) 495-9485 (international) and provide the conference ID: 7123909. The conference call will also be available to interested parties through a live webcast at https://ir.mohawkgp.com/. The archived online replay will be available after the call in the investors section of the Mohawk corporate websiteAbout Mohawk Group Holdings, Inc.Mohawk Group Holdings, Inc. and subsidiaries...

WARMINSTER, Pa., May 04, 2020 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a Hepatitis B Virus (HBV) therapeutic solutions company, today announced that it has scheduled its first quarter financial results, conference call and webcast for Monday, May 11, 2020. The schedule for the press release and conference call/webcast are as follows:A live webcast of the conference call can be accessed through the Investors section of Arbutus’ website at www.arbutusbio.com or directly at Live Webcast.An archived webcast will be available on the Arbutus website after the event. Alternatively, you may access a replay of the conference call by calling (855) 859-2056 or (404) 537-3406, and reference conference ID 2993486.About ArbutusArbutus Biopharma Corporation is a publicly-traded (Nasdaq: ABUS) biopharmaceutical company...

SAN MATEO, Calif., May 04, 2020 (GLOBE NEWSWIRE) — SurveyMonkey (Nasdaq: SVMK) today announced that the Rhode Island Department of Health (RIDOH) has deployed SurveyMonkey’s Enterprise Solution and Salesforce Integration in approximately 11 days to assist in COVID-19 tracking efforts. Through its HIPAA-compliant survey offering, SurveyMonkey enables the RIDOH to monitor all individuals exposed to the coronavirus who opt-in through daily survey links sent via SMS text. The data will help the RIDOH to track and monitor the virus’ impact.“The name of the game here is data. Over time it will be vital for us to have regularly updated information statewide on COVID-19,” said Governor of Rhode Island, Gina Raimondo during a recent press conference addressing these efforts. “That data is going to be gold for us as we manage this crisis—especially...